West Sussex, United Kingdom

Jim Hanson

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Phytopharm Plc. Active years: 2006-2009.

USPTO Granted Patents = 2 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2009

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jim Hanson: Innovator in Dementia Treatment

Introduction

Jim Hanson is a notable inventor based in West Sussex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cognitive dysfunction and dementia. With a total of 2 patents to his name, his work is paving the way for innovative therapeutic solutions.

Latest Patents

Hanson's latest patents include the development of 5-Beta-sapogenin and pseudosapogenin derivatives. These inventions disclose the use of sapogenin derivatives in the treatment of dementia and similar cognitive dysfunctions. The patents also detail methods of treatment and pharmaceutical compositions that can be utilized in clinical settings.

Career Highlights

Jim Hanson is currently associated with Phytopharm Plc, where he continues to advance his research and development efforts. His work focuses on creating effective treatments that address cognitive impairments, which are increasingly prevalent in today's society.

Collaborations

Hanson collaborates with esteemed colleagues such as Yaer Hu and Daryl David Rees. Together, they contribute to the innovative research environment at Phytopharm Plc, enhancing the potential for groundbreaking discoveries in the field of dementia treatment.

Conclusion

Jim Hanson's contributions to the field of dementia treatment through his innovative patents and collaborative efforts highlight his commitment to improving cognitive health. His work is essential in the ongoing fight against cognitive dysfunction and dementia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…